FDA Inspection 1131979 — Medtronic Heart Valves Division

Medtronic Heart Valves Division — FEI 2025587

The FDA completed an inspection of Medtronic Heart Valves Division on Oct 26, 2020 in Santa Ana, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 26, 2020
Fiscal Year
2021
Product Type
Devices
Project Area
Compliance: Devices
Location
Santa Ana, CA (United States)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures
317221 CFR 820.198(c)Investigation of device failures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.